Seqens Seqens

X

Find Radio Compass News for Alunex

PharmaCompass
API SUPPLIERS
API Suppliers

API Suppliers

US DMFs Filed

US DMFs Filed

CEP/COS Certifications

CEP/COS Certifications

0

JDMFs Filed

JDMFs Filed

Other Certificates

Other Certificates

Other Suppliers

Other Suppliers

API REF. PRICE (USD / KG)
41
INTERMEDIATES

0

DOSSIERS // FDF
USA (Orange Book)

USA (Orange Book)

Europe

Europe

Canada

Canada

Australia

Australia

0

South Africa

South Africa

Uploaded Dossiers

Uploaded Dossiers

GLOBAL SALES (USD Million)

U.S. Medicaid

0

Annual Reports

0

EXCIPIENTS
PATENTS & EXCLUSIVITIES

USFDA Orange Book Patents

USFDA Exclusivities

0

DIGITAL CONTENT

Blog #PharmaFlow

News

REF STANDARD

EDQM

0

USP

JP

Other Listed Suppliers

SERVICES

0

left grey arrow
right gray arrow
  • SOLUTION;ORAL - 4MG/5ML;5MG/5ML
  • TABLET;ORAL - 2MG;200MG;30MG
  • TABLET;ORAL - 4MG;200MG;10MG
  • SOLUTION;ORAL - 4MG/5ML;5MG/5ML;60MG/5ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
  • TABLET, EXTENDED RELEASE;ORAL - 12MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
  • TABLET, EXTENDED RELEASE;ORAL - 8MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

https://indianexpress.com/article/cities/delhi/govt-bans-anti-cold-fixed-drug-combination-four-children-9076587/

INDIAN EXPRESS
21 Dec 2023

https://www.businesswire.com/news/home/20220420005058/en

BUSINESSWIRE
26 Apr 2022

https://www.business-standard.com/article/markets/sun-pharma-gains-4-in-2-days-after-launches-cough-syrup-chericof-12-121092900419_1.html

BUSINESS-STANDARD
30 Sep 2021

https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-april-1-2020-1585715681.pdf

FDA
01 Apr 2020

https://www.pharmacompass.com/pdf/news/bayer-issues-voluntary-recall-of-alka-seltzer-plus-products-1521263128.pdf

FDA
17 Mar 2018

https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-january-24-2018-1516779005.pdf

FDA
24 Jan 2018

http://www.prnewswire.com/news-releases/valeant-announces-us-launch-of-siliq-brodalumab-injection-300495089.html

PR NEWSWIRE
28 Jul 2017

https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=206891

FDA
14 Jun 2017

https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=206660

FDA
16 May 2017

http://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/govt-challenges-revocation-of-fdc-drug-ban-in-supreme-court/articleshow/56881659.cms

ECONOMIC TIMES
30 Jan 2017

http://www.fiercepharma.com/marketing/fda-promo-police-slap-four-more-pharmas-year-end-enforcement-spree

Tracy Staton FIERCE PHARMA
30 Dec 2016

http://www.business-standard.com/article/companies/200-out-of-500-combinations-examined-have-been-found-irrational-govt-sources-116111601364_1.html

Veena Mani BUSINESS STANDARD
17 Nov 2016

http://www.pharma-excipients.ch/2016/05/16/compatibility-study-of-paracetamol-chlorpheniramine-maleate-and-phenylephrine-hydrochloride-in-physical-mixtures/

PHARMA-EXCIPIENTS
16 May 2016

http://economictimes.indiatimes.com/industry/healthcare/biotech/healthcare/40-doctors-disagree-with-governments-recent-drug-ban-list-survey/articleshow/51459620.cms

ECONOMIC TIMES
18 Mar 2016

http://www.reuters.com/article/us-india-pfizer-medicine-idUSKCN0WG09H

Zeba Siddiqui REUTERS
15 Mar 2016

http://portal.anvisa.gov.br/wps/content/anvisa+portal/anvisa/sala+de+imprensa/menu+-+noticias+anos/2015/medicamento+resfryneo+esta+suspenso+pela++anvisa

ANVISA
30 Jun 2015

https://www.pharmacompass.com/pdf/news/spriasos-codeine-phosphate-hlorpheniramine-maleate.pdf

FDA
24 Jun 2015
Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty
Post Enquiry
POST ENQUIRY